Several clinical trials of PCSK9 inhibitors in patients with ischemic stroke are ongoing, some studies are looking at the effect of PCSK9 inhibitors on acute stroke, and some studies are looking at the effect of PCSK9 inhibitors on intracranial atherosclerotic plaques. This evidence concerns the gene PCSK9 and ischemic stroke.